Liver transplant linked to significantly extended survival for alcohol-associated disease yet access is not equitable
· Medical Xpressby Research Society on Alcohol
edited by Lisa Lock, reviewed by Andrew Zinin
Lisa Lock
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Chief Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
trusted source
proofread
The GIST Add to Preferred Sources
People with alcohol-associated liver disease who received a liver transplant survived years longer than those who did not, but there are disparities in which patients receive a transplant. A large study published in Alcohol: Clinical and Experimental Research found that liver transplantation was associated with significantly longer survival in both the short term and longer term. Yet, women and African Americans had lower odds of receiving a transplant, even though neither group had a higher risk of death than men or white patients.
The study supports the substantial benefit of liver transplantation for people with alcohol-associated liver disease and highlights a need for policies and practices that ensure equitable access to this life-lengthening treatment.
The study analyzed national insurance claims data of commercially insured and Medicare Advantage patients who were diagnosed with alcohol-associated liver disease from 2017 to 2024, including any preexisting health issues in the 10 years prior to diagnosis.
Unlike most earlier studies, which began follow-up at the time of transplant, this study followed patients from their first diagnosis, capturing the period before transplant when many patients become sicker or die while waiting. The study estimated average survival time within three, five and eight years after diagnosis. The study design and large national cohort provide a real-world view of liver transplantation outcomes.
Of the more than 370,000 patients in the study, about 3,500 received liver transplants. Those who received a liver transplant lived longer over every follow-up period, with 25% to 45% longer average survival time and a 63% lower adjusted risk of death. Over the first eight years after diagnosis, transplant recipients lived, on average, about 7.1 years compared to about 4.9 years for people who did not receive a transplant.
Because this was an observational study and transplant recipients tended to be younger and healthier in other respects, the authors adjusted for these differences; even so, the findings show an association rather than proof that transplantation alone caused the longer survival.
Differences in who did and did not receive liver transplants were evident by age, sex, race and coexisting health conditions. Even after adjusting for liver disease severity and comorbidities, disparities persisted, notably among women and African Americans, who had lower odds of receiving a liver transplant.
People with nonmetastatic liver cancer, people with symptoms of liver decompensation and people with alcohol-associated cirrhosis had increased odds of transplant, whereas people with a recorded diagnosis of alcohol use disorder had less than half the odds. These liver conditions were also associated with a higher risk of death, possibly reflecting delayed referral or advanced disease at the time of transplant evaluation.
The study demonstrates the substantial survival benefit associated with liver transplantation for people with alcohol-associated liver disease and underscores the need for improvements to ensure equitable systems for referral and treatment to eliminate disparities.
More information
Wanzhu Tu et al., Long‐Term Survival of Liver Transplantation in Alcohol‐Associated Liver Disease: Insights From National Claims Data, Alcohol: Clinical and Experimental Research (2026). DOI: 10.1111/acer.70416
Key medical concepts
Clinical categories
Gastroenterology Provided by Research Society on Alcohol Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Liver transplant linked to significantly extended survival for alcohol-associated disease yet access is not equitable (2026, November 9) retrieved 9 November 2026 from https://medicalxpress.com/news/2026-11-liver-transplant-linked-significantly-survival.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.